bioRxiv Science⌕ Search

Biology subjects

Kosonocky, C. W.

Publications and source records attributed to Kosonocky, C. W..

4 recordsLinked to original sources

Learning from human and chemical languages to predict biological function

Understanding how molecular structure encodes biological function remains a grand challenge in drug discovery. Here, we present PubCheF-1, a deep learning model that predicts literature-derived biological function directly from chemical structure. PubCheF-1 was trained on a dataset linking molecules to labels derived from the scientific articles in which they appear, a strategy that connects disparate compounds through the language used to describe their functionalities. When tasked with identifying inhibitors of {beta}-lactamases, including enzymes considered largely refractory to inhibition, PubCheF-1 predicted structurally distinct compounds that collectively have activity against all {beta}-lactamase classes. Furthermore, hit compounds directly bind the enzyme active site, restore antibiotic efficacy in multidrug-resistant high-priority pathogens, and demonstrate potent activity in animal infection models. Together, these findings establish that machine learning-based prediction of biological function derived from the language of scientific literature allows the identification of bioactive molecules at high hit rates, thereby accelerating therapeutic discovery.

bioinformatics↗

Validation and analysis of 12,000 AI-driven CAR-T designs in the Bits to Binders competition

Artificial intelligence (AI) methods for proteins have advanced rapidly, improving structure prediction and design, particularly for de novo binders. However, most evaluations emphasize binding affinity rather than higher-order biological function. We present Bits to Binders, a global competition benchmarking de novo binder design in the context of chimeric antigen receptor (CAR) T cells. Teams from 42 countries submitted 12,000 designs of 80-amino acid binders targeting human CD20 as CAR binding domains. Designs were screened by pooled CAR-T proliferation, identifying 707 designs exhibiting significant CD20-specific enrichment, with team hit rates from 0.6% to 38.4%. Top-performing candidates were validated as individual constructs, measuring CD20-specific proliferation, expansion, cytokine production, and targeted cell lysis. We identified common design methodologies and factors correlated with DNA synthesis, expression, and target-specific T cell activation which nearly double the success rates when applied as a retrospective filter. We release this dataset as an open resource, with practical recommendations to support more effective AI-driven binder design.

bioinformatics↗

Directed evolution of a SelB variant that does not require a SECIS element for function

In bacteria the incorporation of selenocysteine is achieved through the interaction of the selenocysteine specific elongation factor (SelB) with selenocysteine-charged tRNASec and a selenocysteine insertion sequence (SECIS) element adjacent to an opal stop codon in a mRNA. The more generalized, SECIS-independent incorporation of selenocysteine is of interest because of the high nucleophilicity of selenium and the greater durability of diselenide bonds. It is likely that during the course of evolution selenocysteine insertion originally arose without the presence of a SECIS element, relying only on SelB. Herein we undertake experiments to evolve an ancestral version of SelB that is SECIS-independent and show that not only can this protein (SelB-v2) generally incorporate selenocysteine across from stop codons, but also that the new, orthogonal translation factor can be repurposed to other amino acids, such as serine. Given the delicate energetic balancing act already performed by EF-Tu, this achievement raises the possibility that greatly expanded genetic codes that relied in part on SelB-based loading can now be contrived.

synthetic biology↗

Directed evolution of generalist biosensors for single ring aromatics

Biosensors can accelerate the engineering of new biosynthetic pathways. Phloroglucinol is a platform chemical of wide utility that can be produced at limited titers in Escherichia coli. Starting from the TetR family repressor RolR that is responsive to the related compound resorcinol, we were able to employ a combined selection and screen to identify variants that had greatly improved activities with phloroglucinol (EC50 for phloroglucinol of 131 uM, relative to an estimated 42 mM for wild-type RolR). The variants obtained were further screened with a panel of similar single ring aromatics, and several were found to be generalists, consistent with the hypothesis that both natural and directed evolution tend to first create semi-specific pockets prior to further optimization for new function

synthetic biology↗